Acurx制药公司与New to the Street公司合作,通过媒体宣传其抗生素发展。 Acurx Pharmaceuticals partners with New to The Street for media exposure on its antibiotic development.

Acurx制药公司与金融媒体平台New to The Street重新建立了媒体伙伴关系,展示其抗生素发展努力。 Acurx Pharmaceuticals has renewed a media partnership with New to The Street, a financial media platform, to showcase its antibiotic development efforts. 合作内容包括国家电视广告、对Bloomberg和Fox Business的采访、YouTube视频以及社交媒体的存在。 The collaboration involves national TV commercials, interviews on Bloomberg and Fox Business, YouTube videos, and social media presence. Acurx的主要产品候选者Ibezapolstat是治疗C. difficlic 感染的主要产品,定于明年进行第三阶段试验,等待资金到位。 Acurx's lead product candidate, ibezapolstat, for treating C. difficile infection, is set for Phase 3 trials next year, pending financing.